In the push for cannabis legalization, the link between cannabis and schizophrenia sometimes enters the discussion.
Many fear that cannabis increases risk for developing schizophrenia, while others declare its value in helping relieve symptoms of the condition, according to Leafly. But what does the research say about the role of cannabis in developing—and potentially treating—schizophrenia?
Traditional pharmaceutical treatments, though, do little to treat negative symptoms such as a flat emotional state, a struggle to feel pleasure, and a lack of motivation to engage socially. They also fail to improve cognitive deficits, often leaving patients with impaired attention, memory, and problem-solving abilities.